Eric Coldwell

Q: What is Eric Coldwell's success rate?

Eric Coldwell currently has a success rate of 93.34707888460424.

Q: What is the average return of Eric Coldwell's calls?

Their stock ratings have generated an average return of 31.201094615460175.

Baird | Healthcare

Eric Coldwell is an analyst from Baird specializing in the Healthcare sector. Ranked #421 out of 4773 analysts, they have issued 19 stock ratings with a success rate of 93.35% and an average return of 31.20%.

With 19 ratings to date, Eric Coldwell is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 93.35% and an average return of 31.20%, highlighting promising potential as their track record develops further.

#421

Out of 4773

Total Ratings

+93.35%

Success Rate

+31.20%

Average Return

Recent Ratings Analysis

IQV

Buy

Jul 29, 2026

Target

$287.00

Current

$261.77

Performance

5.74%

Eric Coldwell rated IQV as Outperform on Jul 29, 2026, setting a price target of 287. The call has proven timely, with shares rising 5.74% toward the price target of 287.

MEDP

Hold

Jul 24, 2026

Target

$624.00

Current

$587.52

Performance

-2.30%

On Jul 24, 2026, MEDP was given a Neutral rating by Eric Coldwell, with a target price of 624. Market indecision, reflected in sideways trading near 587.52, supported the cautious call.

DGX

Hold

Jul 24, 2026

Target

$255.00

Current

$235.02

Performance

3.14%

DGX received a Neutral rating from Eric Coldwell on Jul 24, 2026, aiming for 255. Shares remained flat at 235.02, aligning with the neutral rating.

LH

Buy

Jul 13, 2026

Target

$338.00

Current

$311.54

Performance

12.60%

On Jul 13, 2026, Eric Coldwell published a Outperform outlook on LH, with a target of 338. Shares gained 12.60%, underscoring the accuracy of the bullish outlook toward 338.

AHCO

Buy

Jul 06, 2026

Target

$15.00

Current

$6.06

Performance

-40.99%

Eric Coldwell on Jul 06, 2026 assigned AHCO a Outperform rating, with a price target of 15. The call has struggled to gain traction, with shares losing 40.99%.

ICLR

Buy

Jun 25, 2026

Target

$186.00

Current

$169.31

Performance

5.19%

On Jun 25, 2026, Eric Coldwell reaffirmed ICLR with a Outperform rating, targeting 186. The recommendation was supported by strong follow-through as the stock rose from 169.31 to 169.31.

MDLN

Buy

Jun 03, 2026

Target

$45.00

Current

$32.53

Performance

-5.63%

MDLN was rated Outperform by Eric Coldwell on Jun 03, 2026, with a price objective of 45. This case shows how bullish projections can fail, with the stock now below 32.53.

ACH

Buy

May 12, 2026

Target

$6.00

Current

$1.08

Performance

-66.25%

On May 12, 2026, Eric Coldwell initiated coverage on ACH with a Outperform rating and target of 6. The Buy call has yet to be validated as shares remain 4.92 away from the target.

FTRE

Buy

Feb 27, 2026

Target

$19.00

Current

$17.20

Performance

60.45%

Eric Coldwell issued a Outperform recommendation for FTRE on Feb 27, 2026, price target set at 19. Investors following the Buy call captured upside momentum, with shares now at 17.2.

MCK

Buy

Nov 06, 2025

Target

$927.00

Current

$881.51

Performance

2.67%

On Nov 06, 2025, MCK was evaluated by Eric Coldwell, who gave a Outperform rating and target of 927. So far, the Buy call awaits clearer momentum, with shares flat at 881.51.

CRL

Buy

Nov 06, 2025

Target

$199.00

Current

$278.26

Performance

62.84%

Eric Coldwell rated CRL as Outperform on Nov 06, 2025, setting a price target of 199. The call has proven timely, with shares rising 62.84% toward the price target of 199.

PINC

Hold

Aug 20, 2025

Target

$27.00

Current

$49.58

Performance

94.05%

On Aug 20, 2025, PINC was given a Neutral rating by Eric Coldwell, with a target price of 27. The stock rallied from 49.58 to 49.58 after the Hold rating, surprising to the upside.

CAH

Buy

Aug 13, 2025

Target

$203.00

Current

$234.57

Performance

58.36%

CAH received a Outperform rating from Eric Coldwell on Aug 13, 2025, aiming for 203. Momentum has favored the Buy call, with shares climbing from 234.57 to 234.57, rewarding those who trusted the recommendation.

OMI

Buy

Aug 12, 2025

Target

$7.00

Current

$2.68

Performance

-51.01%

On Aug 12, 2025, Eric Coldwell published a Outperform outlook on OMI, with a target of 7. Market action contradicted the Buy thesis, as shares slipped to 2.68.

CTLT

Hold

Sep 24, 2024

Target

$63.50

Current

$63.48

Performance

5.55%

Eric Coldwell on Sep 24, 2024 assigned CTLT a Neutral rating, with a price target of 63.5. Shares outperformed expectations, climbing 5.55% despite the neutral view.

Frequency Asked Questions

Who is Eric Coldwell?

Eric Coldwell is an analyst from Baird specializing in the Healthcare sector.

What is Eric Coldwell's success rate?

Eric Coldwell currently has a success rate of +93.35%.

How many ratings has Eric Coldwell issued?

Eric Coldwell has issued 19 stock ratings so far.

What is the average return of Eric Coldwell's calls?

Their stock ratings have generated an average return of +31.20%.

What is Eric Coldwell's ranking?

Eric Coldwell is ranked #421 out of 4773 analysts.

What types of ratings does Eric Coldwell give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Eric Coldwell?

You can follow Eric Coldwell by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Eric Coldwell?

Their latest rating was a Buy on IQV issued on 2026-07-29.